The Biology and Diagnosis of JBS

Understanding the biology of Johanson-Blizzard Syndrome (JBS) helps clarify why it affects so many different parts of the body at once. At its core, JBS is a disorder involving a specific cellular process called the N-end rule pathway, which acts as a “quality control” system for proteins ^[1][2].

The Role of the UBR1 Gene

Every person has two copies of the UBR1 gene, which provides instructions for making an E3 ubiquitin ligase—a protein that acts like a specialized inspector in your cells ^[1].

In a healthy cell, the UBR1 protein identifies other proteins that have specific destabilizing signals and “tags” them for destruction, ensuring the cell remains functional ^[1][2]. In JBS, mutations in the UBR1 gene mean this inspector is either missing or unable to recognize the proteins it needs to tag ^[2]. This is a simplified model, but the disruption of this pathway is particularly damaging to the early development of the pancreas and certain facial features before a baby is even born ^[3][4]. It is important to note that the specific gene mutation does not reliably predict how severe the syndrome will be in an individual child.

How JBS is Inherited

JBS follows an autosomal recessive inheritance pattern. This means that for a child to have the syndrome, they must inherit one changed (mutated) copy of the UBR1 gene from each parent ^[5].

• Carriers: Parents are typically “carriers.” They have one working gene and one changed gene. Because the working gene does its job perfectly, carriers do not have any symptoms of JBS ^[5].
• The 25% Rule: When two carriers have a child, there is a 25% chance with each pregnancy that the child will inherit both changed genes and have JBS. There is a 50% chance the child will be a carrier like their parents, and a 25% chance the child will inherit two working genes ^[5].

The Diagnostic Process

Doctors typically suspect JBS based on clinical observation. The “hallmark” signs that usually trigger testing are exocrine pancreatic insufficiency (difficulty digesting food) and hypoplastic nasal alae (underdeveloped or small nostrils) ^[6][7].

Diagnosis relies on genetic confirmation, though an inconclusive test does not entirely rule out the syndrome. Testing is typically selected by a genetics professional:

1. Gene Sequencing: This is the first step, where the lab “reads” the UBR1 gene to look for spelling errors. This identifies many mutations ^[1].
2. Deletion/Duplication Analysis (such as MLPA): If sequencing is negative or only finds one mutation but the child has clear symptoms, a test to look for missing or extra “pages” of the genetic code is often used. This step increases the ability to find the responsible mutations ^[1]. If both tests are unrevealing, doctors may use larger panels or exome sequencing.

Distinguishing JBS from Similar Conditions

Because JBS involves the pancreas, it can sometimes be confused with other disorders. A geneticist will help rule out mimics:

• Cystic Fibrosis (CF): The most common cause of pancreatic insufficiency in children, but caused by a different gene and lacking the specific facial features of JBS.
• Shwachman-Diamond Syndrome (SDS): Like JBS, children with SDS have pancreatic issues. However, SDS is frequently associated with bone marrow failure (low blood counts) and specific bone abnormalities ^[8]. Molecular testing and blood counts are used to distinguish the two.
• CAPN15-Related Disease: A very rare condition that can overlap with JBS in growth and developmental delays, but typically lacks the specific nasal features seen in JBS ^[9].

By confirming the diagnosis through UBR1 testing, your care team can focus entirely on the management strategies known to help children with Johanson-Blizzard Syndrome ^[10][3].